Taking advantage of technology, highlights from the Committee for Medicinal Products for Human Use (CHMP) meetings can now be viewed online through the European Medicines Agency (EMA) website. The first meeting to have highlights available online can be seen here, from the September 19-22 assembly.
In a press release, the EMA indicated the new format would let users view, ”the main opinions adopted at the meeting, along with information on safety reviews, in a clear tabular format.” Individual press releases and other documents will also be available via links through the online meeting summary.
A new web page will be submitted after each month’s CHMP meeting.
Users can voice their opinion about the new format here. Any changes to the new design will be made in early 2012.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.